These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16261783)

  • 1. Percutaneous closure of a patent foramen ovale: single-centre experience using different types of devices and mid-term outcome.
    Post MC; Van Deyk K; Budts W
    Acta Cardiol; 2005 Oct; 60(5):515-9. PubMed ID: 16261783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale.
    Hornung M; Bertog SC; Franke J; Id D; Taaffe M; Wunderlich N; Vaskelyte L; Hofmann I; Sievert H
    Eur Heart J; 2013 Nov; 34(43):3362-9. PubMed ID: 23842846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications and mid-term outcome after percutaneous patent foramen ovale closure in patients with cryptogenic stroke.
    Luermans JG; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
    Neth Heart J; 2008 Oct; 16(10):332-6. PubMed ID: 18958256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent foramen ovale closure in patients with transient ischemia attack/stroke.
    Sievert H; Horvath K; Zadan E; Krumsdorf U; Fach A; Merle H; Scherer D; Schräder R; Spies H; Nowak B; Lissmann-Jensen H
    J Interv Cardiol; 2001 Apr; 14(2):261-6. PubMed ID: 12053315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
    Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
    Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
    Van de Bruaene A; Stroobants D; Benit E
    Acta Cardiol; 2015 Apr; 70(2):133-40. PubMed ID: 26148372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
    J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure.
    Davies A; Ekmejian A; Collins N; Bhagwandeen R
    Heart Lung Circ; 2017 Mar; 26(3):246-250. PubMed ID: 27555053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten years of experience with closure of persistent foramen ovale: patient characteristics and outcomes.
    Lehmann R; Fichtlscherer S; Baldauf H; Schächinger V; Auch-Schwelck W; Zeiher AM; Teupe C
    J Cardiol; 2014 Aug; 64(2):113-6. PubMed ID: 24480741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm.
    von Bardeleben RS; Richter C; Otto J; Himmrich L; Schnabel R; Kampmann C; Rupprecht HJ; Marx J; Hommel G; Münzel T; Horstick G
    Int J Cardiol; 2009 May; 134(1):33-41. PubMed ID: 18715659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
    Aral M; Mullen M
    Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of occluder device type on success of percutaneous closure of atrial septal defects--a medium-term follow-up study.
    Becker M; Frings D; Schröder J; Ocklenburg C; Mühler E; Hoffmann R; Franke A; Lepper W
    J Interv Cardiol; 2009 Dec; 22(6):503-10. PubMed ID: 19821880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems.
    Braun M; Gliech V; Boscheri A; Schoen S; Gahn G; Reichmann H; Haass M; Schraeder R; Strasser RH
    Eur Heart J; 2004 Mar; 25(5):424-30. PubMed ID: 15033255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent foramen ovale using the Premere device: the results of the CLOSEUP trial.
    Büscheck F; Sievert H; Kleber F; Tiefenbacher C; Krumsdorf U; Windecker S; Uhlemann F; Wahr DW
    J Interv Cardiol; 2006 Aug; 19(4):328-33. PubMed ID: 16881979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
    Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
    Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R
    Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial.
    Hong TE; Thaler D; Brorson J; Heitschmidt M; Hijazi ZM;
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):524-8. PubMed ID: 14624434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous closure of atrial septal defects: immediate and mid-term results.
    Dardas PS; Ninios VN; Mezilis NE; Tsikaderis DD; Thanopoulos VD
    Hellenic J Cardiol; 2010; 51(2):104-12. PubMed ID: 20378511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous closure of the patent foramen ovale using the HELEX® Septal Occluder: acute and long-term results in 405 patients.
    Heinisch C; Bertog S; Wunderlich N; Majunke N; Baranowski A; Leetz M; Fischer E; Staubach S; Zimmermann W; Hofmann I; Sievert H
    EuroIntervention; 2012 Oct; 8(6):717-23. PubMed ID: 23086790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.